BPNT1

gene product
BPNT1, also called bisphosphate 3-prime-nucleotidase, or BPntase, is a member of a magnesium-dependent phosphomonoesterase family. Lithium, a major drug used to treat manic depression, acts as an uncompetitive inhibitor of BPntase. The predicted human protein is 92% identical to mouse BPntase. BPntase's physiologic role in nucleotide metabolism may be regulated by inositol signaling pathways. The inhibition of human BPntase may account for lithium-induced nephrotoxicity. [provided by RefSeq, Jul 2008]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

Antibody

  or   Clear
Enhanced validation
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Validated within AVI
Eligible for validation within AVI
225 antibodies from 29 providers.

Antibody properties

General

Applications

or Cancel
Antibody
antibodies-online
63 antibodies
Novus Biologicals
6 antibodies
Abnova Corporation
7 antibodies
LifeSpan BioSciences, Inc.
28 antibodies
Proteintech Group
1 antibody
NovoPro Bioscience Inc.
3 antibodies
Abgent
1 antibody
Atlas Antibodies
1 antibody
Wuhan Fine Biotech Co., Ltd.
1 antibody
Invitrogen Antibodies
3 antibodies
GeneTex
2 antibodies
Antibodies.com
1 antibody
Acris Antibodies GmbH
4 antibodies
Everest Biotech
1 antibody
NSJ Bioreagents
1 antibody
Biorbyt
8 antibodies
Aviva Systems Biology
3 antibodies
OriGene
3 antibodies
Creative Diagnostics
4 antibodies
Arigo
1 antibody
United States Biological
52 antibodies
ProSci
3 antibodies
MyBioSource
4 antibodies
Leading Biology
2 antibodies
MilliporeSigma / Merck KGaA
2 antibodies
St John's Laboratory
1 antibody
Creative Biolabs
3 antibodies
Abbexa
1 antibody